Hiroaki Shima

576 total citations
36 papers, 336 citations indexed

About

Hiroaki Shima is a scholar working on Cancer Research, Surgery and Oncology. According to data from OpenAlex, Hiroaki Shima has authored 36 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 16 papers in Surgery and 14 papers in Oncology. Recurrent topics in Hiroaki Shima's work include Breast Cancer Treatment Studies (15 papers), Breast Implant and Reconstruction (8 papers) and Breast Lesions and Carcinomas (7 papers). Hiroaki Shima is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Breast Implant and Reconstruction (8 papers) and Breast Lesions and Carcinomas (7 papers). Hiroaki Shima collaborates with scholars based in Japan, Switzerland and United States. Hiroaki Shima's co-authors include Goro Kutomi, Koichi Hirata, Toshihiko Torigoe, Noriyuki Sato, Yasuaki Tamura, Yasutoshi Kimura, Y. Suzuki, Mitsuru Mori, Hidekazu Kameshima and Tousei Ohmura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgical Oncology and World Journal of Surgery.

In The Last Decade

Hiroaki Shima

32 papers receiving 331 citations

Peers

Hiroaki Shima
Hiroki Teraoku Japan
Bao‐Ye Sun China
Takako Nirei Japan
Antonia Wenners Germany
Fuao Cao China
Bangbo Zhao China
Teruhide Ishigame Japan
Juan Ramón Delgado Spain
Hiroki Teraoku Japan
Hiroaki Shima
Citations per year, relative to Hiroaki Shima Hiroaki Shima (= 1×) peers Hiroki Teraoku

Countries citing papers authored by Hiroaki Shima

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Shima more than expected).

Fields of papers citing papers by Hiroaki Shima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Shima. The network helps show where Hiroaki Shima may publish in the future.

Co-authorship network of co-authors of Hiroaki Shima

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Shima. A scholar is included among the top collaborators of Hiroaki Shima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Shima. Hiroaki Shima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shima, Hiroaki, Goro Kutomi, Daisuke Kyuno, et al.. (2024). Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer. Anticancer Research. 44(9). 4039–4047.
2.
Ishitobi, Makoto, Tadahiko Shien, Hiroaki Inoue, et al.. (2024). Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence. Annals of Surgical Oncology. 31(7). 4512–4517. 1 indexed citations
3.
Ishitobi, Makoto, Tadahiko Shien, Hiroaki Inoue, et al.. (2024). ASO Visual Abstract: Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence. Annals of Surgical Oncology. 31(9). 5957–5958.
4.
Hirohashi, Yoshihiko, Goro Kutomi, Kenji Murata, et al.. (2023). Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD‐like receptor family CARD domain‐containing 5. Cancer Science. 114(12). 4511–4520. 5 indexed citations
5.
Ishitobi, Makoto, Hiroaki Shima, Eriko Takahashi, et al.. (2023). Preferences Regarding Breast Surgery Omission Among Patients With Breast Cancer Who Receive Neoadjuvant Chemotherapy. In Vivo. 37(2). 794–800. 5 indexed citations
6.
Shima, Hiroaki, Goro Kutomi, Kiminori Sato, et al.. (2021). An Optimal Timing for Removing a Drain After Breast Surgery: A Systematic Review and Meta-Analysis. Journal of Surgical Research. 267. 267–273. 7 indexed citations
7.
Kutomi, Goro, Hiroaki Shima, Toshio Honma, et al.. (2020). The Unique Mental Impacts of Breast-Conserving Surgery and Mastectomy According to a Multi-Centered Cross Sectional Survey Conducted in Japan. SHILAP Revista de lepidopterología. 119–126. 2 indexed citations
8.
Shima, Hiroaki, Toshitaka Okuno, Takashi Nakamura, et al.. (2020). Comparing the extent of breast cancer tumors through contrast-enhanced ultrasound vs B-mode, opposed with pathology: evergreen study. Breast Cancer. 28(2). 405–413. 9 indexed citations
9.
Sawada, Atsushi, et al.. (2020). Erector spinae plane block versus retrolaminar block for postoperative analgesia after breast surgery: a randomized controlled trial. Journal of Anesthesia. 35(1). 27–34. 21 indexed citations
10.
Shima, Hiroaki, Goro Kutomi, Masafumi Imamura, et al.. (2018). Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine. Cancer Immunology Immunotherapy. 67(10). 1603–1609. 6 indexed citations
11.
Kutomi, Goro, Toru Mizuguchi, Hideki Maeda, et al.. (2017). Current status of the prognostic molecular biomarkers in breast cancer: A systematic review. Oncology Letters. 13(3). 1491–1498. 19 indexed citations
12.
Shima, Hiroaki, Goro Kutomi, Satoko Uno, et al.. (2016). Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases. Surgical Case Reports. 2(1). 54–54. 1 indexed citations
13.
Shima, Hiroaki, Goro Kutomi, Hideki Maeda, et al.. (2014). Risk of node metastasis of sentinel lymph nodes detected in level II/III of the axilla by single-photon emission computed tomography/computed tomography. Experimental and Therapeutic Medicine. 8(5). 1447–1452. 4 indexed citations
14.
Minatoya, Machiko, Goro Kutomi, Hiroaki Shima, et al.. (2014). Relation of Serum Adiponectin Levels and Obesity with Breast Cancer: A Japanese Case-Control Study. Asian Pacific Journal of Cancer Prevention. 15(19). 8325–8330. 17 indexed citations
15.
Kutomi, Goro, Tousei Ohmura, Hideki Maeda, et al.. (2014). A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer. International Journal of Clinical Oncology. 20(3). 474–479. 2 indexed citations
16.
Kutomi, Goro, Yasuaki Tamura, Tsutomu Tanaka, et al.. (2013). Human endoplasmic reticulum oxidoreductin 1‐α is a novel predictor for poor prognosis of breast cancer. Cancer Science. 104(8). 1091–1096. 66 indexed citations
17.
Kutomi, Goro, Hiroaki Shima, Hidekazu Kameshima, et al.. (2013). Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection. Experimental and Therapeutic Medicine. 7(2). 456–460. 5 indexed citations
18.
Kameshima, Hidekazu, Tetsuhiro Tsuruma, Goro Kutomi, et al.. (2012). Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2B‐derived peptide vaccination for advanced pancreatic cancer patients. Cancer Science. 104(1). 124–129. 61 indexed citations
19.
Shima, Hiroaki, Tetsuhiro Tsuruma, Hiroeki Sahara, et al.. (2007). PROTECTIVE MECHANISM OF β-SQAG9 LIPOSOME, A SULFONOGLYCOLIPID EXTRACTED FROM SEA URCHIN INTESTINES, AGAINST HEPATIC ISCHEMIA REPERFUSION INJURY. Shock. 28(1). 94–100. 1 indexed citations
20.
Tsuruma, Tetsuhiro, Hiroeki Sahara, A Yagihashi, et al.. (2004). Synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats. Transplantation Proceedings. 36(7). 1965–1969. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Teraoku Breakdown of academic impact, for papers by Bao‐Ye Sun Breakdown of academic impact, for papers by Takako Nirei Breakdown of academic impact, for papers by Antonia Wenners Breakdown of academic impact, for papers by Fuao Cao Breakdown of academic impact, for papers by Bangbo Zhao Breakdown of academic impact, for papers by Teruhide Ishigame Breakdown of academic impact, for papers by Juan Ramón Delgado
Rankless by CCL
2026